SwePub
Tyck till om SwePub Sök här!
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Pukkala Eero)
 

Sökning: WFRF:(Pukkala Eero) > Early pregnancy IGF...

Early pregnancy IGF-I and placental GH and risk of epithelial ovarian cancer : A nested case-control study

Schock, Helena, 1984- (författare)
Umeå universitet,Patologi,German Cancer Research Center, Heidelberg
Fortner, Renée T (författare)
German Cancer Research Center, Heidelberg
Surcel, Heljä-Marja (författare)
National Institute for Health and Welfare, Oulu, Finland
visa fler...
Grankvist, Kjell, 1954- (författare)
Umeå universitet,Enheten för biobanksforskning,Klinisk kemi
Pukkala, Eero (författare)
School of Public Health, University of Tampere, Finland
Lehtinen, Matti (författare)
School of Public Health, University of Tampere, Finland
Lundin, Eva, 1955- (författare)
Umeå universitet,Patologi
visa färre...
 (creator_code:org_t)
2014-12-17
2015
Engelska.
Ingår i: International Journal of Cancer. - : John Wiley & Sons. - 0020-7136 .- 1097-0215. ; 137:2, s. 439-447
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Insulin-like growth factor-I (IGF-I) signaling may promote ovarian tumor development by exerting mitotic, antiapoptotic and proangiogenic effects. During pregnancy, maternal production of IGF-I is regulated by placental growth hormone (GH). Parity is an established protective factor for ovarian cancer, however, no prior study has evaluated placental GH and IGF-I in pregnancy and epithelial ovarian cancer (EOC). Prior prospective studies on the association between IGF-I and EOC in nonpregnant populations were inconclusive and did not address associations in subtypes of EOC. Among members of the Finnish Maternity Cohort and the Northern Sweden Maternity Cohort, we identified 1,045 EOC cases, diagnosed after recruitment (1975-2008) and before March 2011 and 2,658 individually matched controls. Placental GH and IGF-I were measured in serum from the last pregnancy before EOC diagnosis or selection as control. We used conditional logistic regression to estimate odds ratios (ORs) and 95% confidence intervals (CIs) for tertiles and a doubling of hormone concentrations. Higher IGF-I was associated with a nonsignificant decrease in risk for invasive [ORT3 vs. T1 : 0.79 (0.62-1.02); ptrend  = 0.07] and endometrioid tumors [ORT3 vs. T1 : 0.55 (0.28-1.07); ptrend  = 0.07]. The protective association between higher IGF-I levels and risk of invasive EOC was stronger in analyses limited to women aged <55 years at diagnosis [ORT3 vs. T1 : 0.74 (0.57-0.96); ptrend  = 0.03]. Our study provides the first data on placental GH and IGF-I in pregnancy and EOC risk overall and by subtype. Our data suggest higher IGF-I levels in pregnancy may be associated with lower risk of invasive and endometrioid EOC.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
LANTBRUKSVETENSKAPER  -- Veterinärmedicin -- Medicinsk biovetenskap (hsv//swe)
AGRICULTURAL SCIENCES  -- Veterinary Science -- Medical Bioscience (hsv//eng)

Nyckelord

placental GH
IGF-I
ovarian neoplasms
pregnancy
prospective studies
Pathology
patologi

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy